Dr Sarah Partridge

 Professional experience

• More than 30 years of experience
• Consultant Clinical Oncologist, Charing Cross Hospital, West London (2000-present)
• Consultant Clinical Oncologist, Imperial College Healthcare NHS Trust, London (2017-present)
• Consultant (Sabbatical) Clinical Oncologist, Mount Vernon Cancer Centre - ENHNT (2016-2017)
• Consultant Clinical Oncologist, Imperial Healthcare NHS Trust (2013-2016)
• Consultant Clinical Oncologist, Kingston and Imperial Healthcare Trusts (2002-2013)
• Consultant (Locum) Clinical Oncologist, Mount Vernon Hospital, Middlesex (2001-2002)
• Registrar Clinical Oncologist, St Thomas’ & Guy’s Hospitals, London (2001)
• Registrar Clinical Oncologist, Charing Cross Hospital, London (2000-2001)

...

 Sub-specialties

• Clinical oncology 
• Head and neck cancer
• Thyroid cancer
• Radio Frequency Ablation (RFA)
• Chemotherapy
• Immunotherapy
• Hypnotherapy
• Integrative holistic care
• Postoperative radiotherapy
• Radiotherapy
• Radiotherapy IMRT
• Radiotherapy IGRT

...

 Positions in public associations

• Honourary Secretary for the Council for Hypnosis and Psychosomatic Medicine at the Royal Society of Medicine.
• Primary Investigator for the VOLUME Study at Charing Cross (Sponsored by Bristol Myers Squibb) assessing the Retrospective experience of use of Nivolumab in the real world in patients with squamous cell Carcinoma Of the head & Neck (scchn) from Dec 2020

 Teaching posts

• College Representative for the Royal College of Radiologists.
• Member of the Council for Hypnosis and Psychosomatic Medicine at the Royal Society of Medicine.
• She plays an active role in specialist training support within oncology.

...

 Education

• Good Clinical Practice Certification (refresher course) (2020)
• Diploma in Clinical Hypnotherapy (London College of Clinical Hypnosis) (Distinction) (2004)
• Certification of Completion of Specialist Training (2001)
• Research fellowship in Vancouver, Canada (1999-2000)
• Research fellowship in Vancouver, Canada (1999-2000)
• FRCR (1998)
• MBBS (Lond.) Guy’s and St Thomas’ Hospital, London (1990)
• Cheltenham College, Cheltenham, Gloucestershire (1985)

...

 Publications and conferences

• Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer JAMA Oncol. 2019;5(12):1774-1778. doi:10.1001/jamaoncol.2019.2785
• Neoadjuvant Docetaxel/platinum/fluouracil (TPF) chemotherapy prior to concurrent chemoradiation in locally advanced head and neck cancer: a single institution study of acute toxicity and response evaluation. O.Hatcher, G. Anand, R.Wolfe, Elika Kashef, Gita Modani, S. Partridge, S. Stewart. Poster Presentation at 4th European Conference on Head & Neck Oncology in Athens 4-6 March 2010 Abstract: Eur Arch Otorhinolaryngol (2010) 267 (Suppl 1) S1-S117 (PP166)
• Capnometry during Carbogen Breathing with Radiotherapy: Ensuring Use of a Dependable Gas Administration System. S. Partridge, C. Aquino-Parsons, A. Green, British Columbia Cancer Agency. Abstract: Int J Radiat Oncol Biol Phys 2002;54(2):122. Oral presentation at ASTRO, New Orleans, Oct. 2002.
• Comparison of Intratumoural Oxygenation using the Comet Assay following 2.5% and 5% Carbogen and 100% Oxygen. S. Partridge1, C. Aquino-Parsons, P. Olive. Vancouver Cancer Centre Int. Journal of Radiation Oncology Biology Physics 2000;46(3):780 (Abstract), Int J Radiat Oncol Biol Phys 2001 Feb 1;49(2):575-580. Presented at the First International Conference on Translational Research in Radio- Oncology, Lugano, Switzerland, March 2000.
• The role of PET Scanning in the Staging of Hodgkin's Disease. S. Partridge, A.Timothy, M. O’Doherty, S. Hain, S. Rankin & G.Mikaeel, Ann Oncol. 2000 Oct;11(10):1273-9. Presented Oct.1999 at Institute of Clinical PET Conference in Vancouver (‘Honourable Mention’ awarded).
• Fluorodeoxyglucose Positron Emission Tomography in the initial Staging of Germ cell tumours. SF Hain, MJ O’Doherty, AR Timothy, MD Leslie, SE Partridge, RA Huddart. Eur. J. Nucl. Med. 27 (5): 590-4, 2000 May.
• Myelodysplastic Syndrome as a complication of neo-adjuvant triple-M chemotherapy and radiotherapy. S. Partridge , C. Lowdell. Clinical Oncology (1999) 11: 187-189. Selected for poster presentation at the Autumn meeting of the Royal College of Radiologists, November 1997.
• Infusional 5-Fluorouracil Can be a Pain in the Neck : A Case for Repositioning Displaced Hickman Lines S.Partridge, M Leslie, A. Irvine, St Thomas' Hospital.Clinical Oncology (1999)11:274-276.

...

 Prizes and awards

• Henry Myers Exhibition for Psychological Medicine